HEADER APOPTOSIS 14-DEC-17 6BW8
TITLE MCL-1 COMPLEXED WITH SMALL MOLECULES
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-
COMPND 3 1;
COMPND 4 CHAIN: A, B, C, D;
COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN
COMPND 6 EAT/MCL1,MCL1/EAT;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MCL1, BCL2L3;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS MCL-1 INHIBITOR, CANCER, STRUCTURE-BASED DESIGN, DRUG DISCOVERY,
KEYWDS 2 APOPTOSIS
EXPDTA X-RAY DIFFRACTION
AUTHOR B.ZHAO
REVDAT 5 04-OCT-23 6BW8 1 REMARK
REVDAT 4 04-DEC-19 6BW8 1 REMARK
REVDAT 3 04-APR-18 6BW8 1 JRNL
REVDAT 2 21-MAR-18 6BW8 1 JRNL
REVDAT 1 31-JAN-18 6BW8 0
JRNL AUTH S.SHAW,Z.BIAN,B.ZHAO,J.C.TARR,N.VEERASAMY,K.O.JEON,J.BELMAR,
JRNL AUTH 2 A.L.ARNOLD,S.A.FOGARTY,E.PERRY,J.L.SENSINTAFFAR,D.V.CAMPER,
JRNL AUTH 3 O.W.ROSSANESE,T.LEE,E.T.OLEJNICZAK,S.W.FESIK
JRNL TITL OPTIMIZATION OF POTENT AND SELECTIVE TRICYCLIC INDOLE
JRNL TITL 2 DIAZEPINONE MYELOID CELL LEUKEMIA-1 INHIBITORS USING
JRNL TITL 3 STRUCTURE-BASED DESIGN.
JRNL REF J. MED. CHEM. V. 61 2410 2018
JRNL REFN ISSN 1520-4804
JRNL PMID 29323899
JRNL DOI 10.1021/ACS.JMEDCHEM.7B01155
REMARK 2
REMARK 2 RESOLUTION. 2.90 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (1.12_2829: ???)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 54.420
REMARK 3 COMPLETENESS FOR RANGE (%) : 89.5
REMARK 3 NUMBER OF REFLECTIONS : 19827
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.238
REMARK 3 R VALUE (WORKING SET) : 0.235
REMARK 3 FREE R VALUE : 0.251
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.770
REMARK 3 FREE R VALUE TEST SET COUNT : 1943
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 26.0584 - 6.9502 0.90 1450 158 0.1990 0.1924
REMARK 3 2 6.9502 - 5.5339 0.85 1356 155 0.2491 0.3035
REMARK 3 3 5.5339 - 4.8395 0.83 1296 139 0.2296 0.2594
REMARK 3 4 4.8395 - 4.3993 0.83 1331 142 0.2131 0.2593
REMARK 3 5 4.3993 - 4.0853 0.83 1304 147 0.2371 0.2364
REMARK 3 6 4.0853 - 3.8452 0.82 1295 145 0.2324 0.2200
REMARK 3 7 3.8452 - 3.6532 0.82 1310 143 0.2465 0.2795
REMARK 3 8 3.6532 - 3.4945 0.82 1290 135 0.2473 0.2556
REMARK 3 9 3.4945 - 3.3603 0.80 1265 146 0.2514 0.2797
REMARK 3 10 3.3603 - 3.2446 0.79 1221 129 0.2544 0.3061
REMARK 3 11 3.2446 - 3.1433 0.78 1259 143 0.2609 0.2754
REMARK 3 12 3.1433 - 3.0536 0.77 1169 129 0.2712 0.2700
REMARK 3 13 3.0536 - 2.9733 0.75 1199 129 0.2812 0.3064
REMARK 3 14 2.9733 - 2.9009 0.69 1099 131 0.2845 0.2591
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.420
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.006 4993
REMARK 3 ANGLE : 0.992 6759
REMARK 3 CHIRALITY : 0.057 718
REMARK 3 PLANARITY : 0.006 847
REMARK 3 DIHEDRAL : 5.880 2904
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: ALL
REMARK 3 ORIGIN FOR THE GROUP (A): 8.2411 27.7770 26.0701
REMARK 3 T TENSOR
REMARK 3 T11: 0.2684 T22: 0.3204
REMARK 3 T33: 0.1572 T12: -0.0327
REMARK 3 T13: 0.0329 T23: 0.0062
REMARK 3 L TENSOR
REMARK 3 L11: 0.5688 L22: 0.4620
REMARK 3 L33: 0.5861 L12: 0.0849
REMARK 3 L13: 0.1665 L23: 0.1041
REMARK 3 S TENSOR
REMARK 3 S11: 0.0672 S12: -0.1104 S13: -0.0791
REMARK 3 S21: 0.0708 S22: -0.0619 S23: -0.0214
REMARK 3 S31: 0.1060 S32: -0.1522 S33: 0.0223
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6BW8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-18.
REMARK 100 THE DEPOSITION ID IS D_1000231690.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 25-OCT-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 21-ID-F
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19873
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900
REMARK 200 RESOLUTION RANGE LOW (A) : 40.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6
REMARK 200 DATA REDUNDANCY : 3.500
REMARK 200 R MERGE (I) : 0.08300
REMARK 200 R SYM (I) : 0.06800
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95
REMARK 200 COMPLETENESS FOR SHELL (%) : 76.0
REMARK 200 DATA REDUNDANCY IN SHELL : 2.30
REMARK 200 R MERGE FOR SHELL (I) : 0.32800
REMARK 200 R SYM FOR SHELL (I) : 0.38800
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 4ZBF
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 67.12
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.74
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20%-30% PEG3350, MAGNESIUM CHLORIDE,
REMARK 280 BIS-TRIS, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 67.69850
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3, 4
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 4
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ALA A 170
REMARK 465 ASP A 171
REMARK 465 VAL A 321
REMARK 465 GLU A 322
REMARK 465 ASP A 323
REMARK 465 LEU A 324
REMARK 465 GLU A 325
REMARK 465 GLY A 326
REMARK 465 GLY A 327
REMARK 465 ALA B 170
REMARK 465 ASP B 171
REMARK 465 THR B 196
REMARK 465 LYS B 197
REMARK 465 GLU B 322
REMARK 465 ASP B 323
REMARK 465 LEU B 324
REMARK 465 GLU B 325
REMARK 465 GLY B 326
REMARK 465 GLY B 327
REMARK 465 ALA C 170
REMARK 465 ASP C 171
REMARK 465 ASP C 195
REMARK 465 THR C 196
REMARK 465 SER C 202
REMARK 465 GLY C 203
REMARK 465 VAL C 321
REMARK 465 GLU C 322
REMARK 465 ASP C 323
REMARK 465 LEU C 324
REMARK 465 GLU C 325
REMARK 465 GLY C 326
REMARK 465 GLY C 327
REMARK 465 ALA D 170
REMARK 465 ASP D 171
REMARK 465 VAL D 321
REMARK 465 GLU D 322
REMARK 465 ASP D 323
REMARK 465 LEU D 324
REMARK 465 GLU D 325
REMARK 465 GLY D 326
REMARK 465 GLY D 327
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LEU A 174 CG CD1 CD2
REMARK 470 LYS A 194 CG CD CE NZ
REMARK 470 MET A 199 CE
REMARK 470 ARG A 201 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 208 CG CD CE NZ
REMARK 470 ASN A 282 CG OD1 ND2
REMARK 470 LYS A 308 CD CE NZ
REMARK 470 GLU B 173 CG CD OE1 OE2
REMARK 470 ASP B 195 CG OD1 OD2
REMARK 470 MET B 199 CG SD CE
REMARK 470 LYS B 244 CD CE NZ
REMARK 470 SER B 255 OG
REMARK 470 ARG B 310 CG CD NE CZ NH1 NH2
REMARK 470 LEU C 174 CD1 CD2
REMARK 470 LYS C 208 CE NZ
REMARK 470 LYS C 276 CA CG CD CE NZ
REMARK 470 LYS C 279 CD CE NZ
REMARK 470 LEU C 306 CG CD1 CD2
REMARK 470 THR D 196 OG1 CG2
REMARK 470 MET D 199 SD CE
REMARK 470 SER D 202 OG
REMARK 470 SER D 245 CB OG
REMARK 470 LYS D 279 CD CE NZ
REMARK 470 ARG D 310 CG CD NE CZ NH1 NH2
REMARK 470 GLU D 317 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O VAL C 297 OG1 THR C 301 2.13
REMARK 500 NH2 ARG A 176 O ARG A 201 2.15
REMARK 500 N LYS A 238 OD2 ASP A 242 2.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 195 159.47 65.23
REMARK 500 PRO A 198 -153.76 -75.75
REMARK 500 SER A 255 -131.15 35.79
REMARK 500 ASN A 282 -4.00 54.39
REMARK 500 ARG B 215 -70.99 -53.75
REMARK 500 SER B 255 -76.13 -71.84
REMARK 500 GLN B 283 50.53 -117.87
REMARK 500 ARG B 310 -41.57 65.06
REMARK 500 PHE B 319 59.23 -108.30
REMARK 500 GLN C 283 52.29 -118.64
REMARK 500 ASP D 195 103.63 60.04
REMARK 500 LYS D 244 69.61 -68.62
REMARK 500 SER D 245 0.03 -172.37
REMARK 500 SER D 255 -157.92 -80.53
REMARK 500 ASP D 256 86.17 52.72
REMARK 500 GLN D 283 53.83 -142.51
REMARK 500 ARG D 310 -94.49 70.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ECM A 400
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ECM B 400
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ECM C 400
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ECM D 400
DBREF 6BW8 A 172 327 UNP Q07820 MCL1_HUMAN 172 327
DBREF 6BW8 B 172 327 UNP Q07820 MCL1_HUMAN 172 327
DBREF 6BW8 C 172 327 UNP Q07820 MCL1_HUMAN 172 327
DBREF 6BW8 D 172 327 UNP Q07820 MCL1_HUMAN 172 327
SEQADV 6BW8 ALA A 170 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ASP A 171 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ALA B 170 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ASP B 171 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ALA C 170 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ASP C 171 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ALA D 170 UNP Q07820 EXPRESSION TAG
SEQADV 6BW8 ASP D 171 UNP Q07820 EXPRESSION TAG
SEQRES 1 A 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE
SEQRES 2 A 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP
SEQRES 3 A 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS
SEQRES 4 A 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN
SEQRES 5 A 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS
SEQRES 6 A 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER
SEQRES 7 A 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN
SEQRES 8 A 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE
SEQRES 9 A 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS
SEQRES 10 A 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL
SEQRES 11 A 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP
SEQRES 12 A 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU
SEQRES 13 A 158 GLY GLY
SEQRES 1 B 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE
SEQRES 2 B 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP
SEQRES 3 B 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS
SEQRES 4 B 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN
SEQRES 5 B 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS
SEQRES 6 B 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER
SEQRES 7 B 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN
SEQRES 8 B 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE
SEQRES 9 B 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS
SEQRES 10 B 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL
SEQRES 11 B 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP
SEQRES 12 B 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU
SEQRES 13 B 158 GLY GLY
SEQRES 1 C 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE
SEQRES 2 C 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP
SEQRES 3 C 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS
SEQRES 4 C 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN
SEQRES 5 C 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS
SEQRES 6 C 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER
SEQRES 7 C 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN
SEQRES 8 C 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE
SEQRES 9 C 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS
SEQRES 10 C 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL
SEQRES 11 C 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP
SEQRES 12 C 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU
SEQRES 13 C 158 GLY GLY
SEQRES 1 D 158 ALA ASP ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE
SEQRES 2 D 158 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP
SEQRES 3 D 158 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS
SEQRES 4 D 158 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN
SEQRES 5 D 158 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS
SEQRES 6 D 158 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER
SEQRES 7 D 158 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN
SEQRES 8 D 158 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE
SEQRES 9 D 158 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS
SEQRES 10 D 158 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL
SEQRES 11 D 158 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP
SEQRES 12 D 158 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU
SEQRES 13 D 158 GLY GLY
HET ECM A 400 50
HET ECM B 400 50
HET ECM C 400 50
HET ECM D 400 50
HETNAM ECM 7-{8-CHLORO-11-[3-(4-CHLORO-3,5-DIMETHYLPHENOXY)
HETNAM 2 ECM PROPYL]-1-OXO-7-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)-4,5-
HETNAM 3 ECM DIHYDRO-1H-[1,4]DIAZEPINO[1,2-A]INDOL-2(3H)-YL}-1-
HETNAM 4 ECM METHYL-1H-INDOLE-3-CARBOXYLIC ACID
FORMUL 5 ECM 4(C39 H39 CL2 N5 O4)
HELIX 1 AA1 ASP A 172 GLY A 192 1 21
HELIX 2 AA2 SER A 202 HIS A 224 1 23
HELIX 3 AA3 HIS A 224 ASP A 236 1 13
HELIX 4 AA4 ASN A 239 SER A 255 1 17
HELIX 5 AA5 ASN A 260 ILE A 281 1 22
HELIX 6 AA6 GLN A 283 SER A 285 5 3
HELIX 7 AA7 CYS A 286 GLN A 309 1 24
HELIX 8 AA8 GLY A 311 PHE A 319 1 9
HELIX 9 AA9 GLU B 173 GLY B 192 1 20
HELIX 10 AB1 SER B 202 HIS B 224 1 23
HELIX 11 AB2 HIS B 224 ASP B 236 1 13
HELIX 12 AB3 ASN B 239 SER B 245 1 7
HELIX 13 AB4 LEU B 246 SER B 255 1 10
HELIX 14 AB5 ASN B 260 ILE B 281 1 22
HELIX 15 AB6 GLN B 283 SER B 285 5 3
HELIX 16 AB7 CYS B 286 LYS B 308 1 23
HELIX 17 AB8 GLY B 311 PHE B 319 1 9
HELIX 18 AB9 GLU C 173 GLY C 192 1 20
HELIX 19 AC1 THR C 205 HIS C 224 1 20
HELIX 20 AC2 HIS C 224 ASP C 236 1 13
HELIX 21 AC3 ASN C 239 SER C 245 1 7
HELIX 22 AC4 LEU C 246 ASP C 256 1 11
HELIX 23 AC5 ASN C 260 ILE C 281 1 22
HELIX 24 AC6 GLN C 283 SER C 285 5 3
HELIX 25 AC7 CYS C 286 GLN C 309 1 24
HELIX 26 AC8 GLY C 311 HIS C 320 1 10
HELIX 27 AC9 GLU D 173 GLY D 192 1 20
HELIX 28 AD1 SER D 202 ARG D 222 1 21
HELIX 29 AD2 HIS D 224 ASP D 236 1 13
HELIX 30 AD3 ASN D 239 LYS D 244 1 6
HELIX 31 AD4 LEU D 246 SER D 255 1 10
HELIX 32 AD5 ASN D 260 ILE D 281 1 22
HELIX 33 AD6 GLN D 283 SER D 285 5 3
HELIX 34 AD7 CYS D 286 GLN D 309 1 24
HELIX 35 AD8 GLY D 311 PHE D 319 1 9
SITE 1 AC1 13 HIS A 224 ALA A 227 PHE A 228 MET A 231
SITE 2 AC1 13 MET A 250 VAL A 253 ASN A 260 ARG A 263
SITE 3 AC1 13 THR A 266 LEU A 267 PHE A 270 GLY A 271
SITE 4 AC1 13 HIS B 320
SITE 1 AC2 13 ARG A 310 ALA B 227 PHE B 228 MET B 231
SITE 2 AC2 13 MET B 250 VAL B 253 PHE B 254 VAL B 258
SITE 3 AC2 13 ASN B 260 ARG B 263 THR B 266 LEU B 267
SITE 4 AC2 13 PHE B 270
SITE 1 AC3 15 HIS A 252 HIS C 224 ALA C 227 PHE C 228
SITE 2 AC3 15 MET C 231 VAL C 249 VAL C 253 PHE C 254
SITE 3 AC3 15 ASN C 260 ARG C 263 THR C 266 LEU C 267
SITE 4 AC3 15 PHE C 270 GLY C 271 ILE C 294
SITE 1 AC4 9 ALA D 227 PHE D 228 MET D 231 MET D 250
SITE 2 AC4 9 VAL D 253 ARG D 263 LEU D 267 PHE D 270
SITE 3 AC4 9 GLY D 271
CRYST1 39.178 135.397 95.750 90.00 90.12 90.00 P 1 21 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025525 0.000000 0.000053 0.00000
SCALE2 0.000000 0.007386 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010444 0.00000